Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

Haematologica. 2016 Feb;101(2):e69-71. doi: 10.3324/haematol.2015.128215. Epub 2015 Oct 15.
No abstract available

Keywords: flow cytometry; induction; minimal residual disease; myeloma.

Publication types

  • Clinical Trial, Phase III
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Antigens, CD / genetics
  • Antigens, CD / metabolism
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Gene Expression
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Induction Chemotherapy / methods*
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / mortality
  • Multiple Myeloma / pathology
  • Multiple Myeloma / therapy*
  • Neoplasm, Residual
  • Prognosis
  • Remission Induction
  • Survival Analysis
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Antigens, CD